Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 23, 2021

View Archived Issues

A virus-specific nanobody lowers latent viral loads in HCMV-infected cells

Clinical hold extended for ORTHO-R phase I/II study

Genexine describes anti-TAA, anti-PD-L1, TNFRSF9 ligand fusion proteins

Sumitomo Dainippon Pharma Oncology patents serine/threonine kinase Nek2 inhibitors

New SREBP inhibitors identified at Capulus Therapeutics

Shanghai Bowei Biological Technology, collaborators divulge polynucleotides for expressing HPV 51L1

KIN-001 for COVID-19 shows preclinical antiviral, anti-inflammatory and antifibrotic activity

APP gene mutation causes autosomal dominant Alzheimer's disease

Salicylanilide compounds show promise for treating COVID-19

Improved serum metabolic profile and symptoms in patients with ALS treated with ILB

AAV gene therapy targeting CaMKII protects retinal ganglion cells, preserves vision

ACMT reports on patients becoming ill from use of ivermectin for COVID-19

Bavarian Nordic studies ABNCoV2 as COVID-19 booster vaccine in phase II

FDA clears IND for clinical trials of siroquine for newly diagnosed GBM

Phase I data reported for GDC-3280 in healthy subjects

Cytokine-induced JAK/STAT signaling plays role in cachexia

KalVista gains clinical trial approvals for phase II trial of KVD-824 for HAE

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...